Newlink Genetics reported $-8835000 in EBIT for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Agenus AGEN:US USD -57622000 15.97M
Bristol Myers Squibb BMY:US USD 2.32B 418M
Eli Lilly And LLY:US USD 2.11B 169.2M
Idera Pharmaceuticals IDRA:US USD -3689000 1.68M
Intrexon XON:US USD -21797000 14.18M
Merk MRK:US USD 4.81B 725M
Nektar Therapeutics NKTR:US USD -40889000 3.42M
Newlink Genetics NLNK:US USD -8835000 1.28M
Pfizer PFE:US USD 5.81B 3.89B
Prothena PRTA:US USD -72000 50.26M
Sarepta Therapeutics SRPT:US USD -106833000 24.52M
Vascular Biogenics VBLT:US USD -3400000 5.88M
YTE INCY:US USD 93.36M 24.89M